Navigation Links
EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States
Date:9/30/2009

ROCKLAND, Mass., Sept. 30 /PRNewswire/ -- EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS). Cladribine Tablets has the potential to be the first orally administered disease-modifying therapy available for people living with relapsing MS, as all disease-modifying therapies currently approved for the treatment of MS are parenteral therapies.

"As a leader in the area of neurodegenerative diseases, we continue to focus on making a positive difference in the lives of people living with MS, and their families," said Fereydoun Firouz, President and CEO of EMD Serono, Inc. "If approved, short-course therapy with Cladribine Tablets could transform the way people approach their treatment options, and meet an unmet need as an oral, disease modifying drug available for MS. We look forward to working with the FDA during the course of the regulatory process."

The NDA submission is supported by results from the CLARITY(a) study, a two-year, randomized, double-blind, placebo-controlled Phase III trial of Cladribine Tablets in people with relapsing-remitting MS. The NDA also shows that all primary and secondary endpoints of the CLARITY trial were met. The CLARITY data were presented at the 61st Annual Meeting of the American Academy of Neurology (AAN) in April 2009 and at other recent international scientific meetings.

(a) CLARITY: CLAdRIbine Tablets Treating MS OrallY

About the CLARITY study

The CLARITY study was a two-year (96-week), randomized, double-blind, placebo-controlled, international trial. It randomized 1,326 patients with relapsing-remitting MS according to the revised McDonald criter
'/>"/>

SOURCE EMD Serono, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
2. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
3. Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
4. Merck Seronos Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinsons Disease in a Phase III Pivotal Trial
5. Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
6. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
7. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
8. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
9. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
10. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
11. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... NORTHVILLE, Mich. , July 29, 2015  Medical ... response systems for seniors, today announced availability of its ... alert system . Worn around the neck or on ... 24/7 from anywhere in the USA ... AWAY ELITE represents the next generation in mobile and ...
(Date:7/29/2015)... Washington , 29. Juli 2015 /PRNewswire/ ... Diabeteszentrums wurde festgestellt, dass die tägliche Einnahme ... Nutraceutix die menschliche Darmflora anreichert und die ... erhöhen. Die Studie umfasste die tägliche Einnahme ... SD-5865) in Tablettenform unter Verwendung der patentierten ...
(Date:7/29/2015)... July 29, 2015 Commenting on ... closed, CFO Simon Dingemans reveals sales rose ... performing in line with expectations. Ahead of a November ... sustainable innovation. The interview and transcript are ... produces in-depth interviews, documentaries and webcasts with senior company ...
Breaking Medicine Technology:New Medical Care Alert Pendant Combines GPS, Cellular Voice, and Automatic Fall Detection 2New Medical Care Alert Pendant Combines GPS, Cellular Voice, and Automatic Fall Detection 3New Medical Care Alert Pendant Combines GPS, Cellular Voice, and Automatic Fall Detection 4Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2
... Aethlon Medical, Inc., (OTCBB: AEMD) disclosed today that its ... following letter to shareholders. (Photo:   ... Last December, I authored a shareholder letter which referenced ... for innovative new therapeutic strategies to evolve as escalating ...
... Name Medical Center (HNMC) in Teaneck, NJ, announced ... Management (PM) and revenue cycle management (RCM) software ... for distribution to hospital-affiliated physicians under the federal ... testing—including speed, functionality, and interfaces—to reach this benchmark. ...
Cached Medicine Technology:Aethlon Medical Releases Shareholder Letter 2Aethlon Medical Releases Shareholder Letter 3Aethlon Medical Releases Shareholder Letter 4Aprima Earns High Marks at Holy Name Medical Center 2Aprima Earns High Marks at Holy Name Medical Center 3
(Date:7/29/2015)... ... ... According to the Miami Herald on July 18th acupuncture helps calm ... may begin taking off in the South Florida community as more detox centers explore ... not a new practice, it is not widely used, but has yielded positive results ...
(Date:7/29/2015)... Waukesha, WI (PRWEB) , ... July 29, 2015 ... ... area, Scott Campbell Agency has once again teamed up with Stillwaters Cancer Support ... patients and their families. Stillwaters provides individual and family counseling, support groups, workshops ...
(Date:7/29/2015)... ... 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of Burlington County ... System, a new implant to treat a common source of shoulder pain and disability. ... additional tendon tissue, which could allow for faster healing and a decreased chance of ...
(Date:7/29/2015)... ... ... Today marks a significant achievement in bringing new monies into early stage companies. ... a group of experienced investors, has tapped into an investor community passionate about Sofia’s ... part of the fund. The Sofia Fund II is now closed to investors, ...
(Date:7/29/2015)... ... ... are privileged to announce that U.S. News & World Report has ranked the ... the nation for 2015-2016. This marks the 21st consecutive year that the USC Eye Institute ... honor to be included in the top 10 ophthalmology hospitals by U.S. News & World ...
Breaking Medicine News(10 mins):Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:Sofia Fund Surpasses Investor Goals 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3
... AMDL, Inc., (NYSE Alternext ... China and the US, today announced financial results for ... the 12 months ended December 31, 2008, the Company ... revenues increased over 124%, reaching just over $33.6 million ...
... 15 MedQuist Inc. (Nasdaq: MEDQ ) ... its new Chief Financial Officer. He joined MedQuist ... MedQuist,s new CFO, Golio is responsible for directing all ... treasury, financial analysis, investor relations, tax, and financial reporting. ...
... YORK, April 15 Lilly Pulitzer has always been ... colors to a worthy cause. To cap off the brand,s ... special project called A Colorful Cause ... Debra Messing, Marcia Cross, Angie Harmon, Bridget Moynahan, Gwyneth Paltrow, Catherine ...
... Calif., April 15 TorreyPines Therapeutics, Inc. (Nasdaq: ... has hired Merriman Curhan Ford as its financial ... options, including the possible sale of the Company ... Therapeutics, Inc. is a biopharmaceutical company committed to ...
... ROCKVILLE, Md., April 15 A new series of ... get involved in their health care by knowing and ... clinicians was launched today by the U.S. Department of ... Quality with The Advertising Council and actress and health ...
... for First-Year Nurses Jeopardizes Quality of Patient Care-- UHC/AACN Nurse ... Average -- Retention Efforts Save Houston ... Than $700,000 OAK BROOK, Ill., April 15 ... the White House spotlighted the nursing shortage, which threatens the ...
Cached Medicine News:Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 2Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 3Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 4Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 5Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 6Health News:MedQuist Names Dominick J. Golio as Chief Financial Officer 2Health News:Lilly Pulitzer(R) Launches A Colorful Cause Celebrity Designed Collection for EBMRF 2Health News:TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives 2Health News:AHRQ and Ad Council Encourage Consumers to Ask Questions and Get More Involved in Their Health Care 2Health News:AHRQ and Ad Council Encourage Consumers to Ask Questions and Get More Involved in Their Health Care 3Health News:Nationwide Nursing Shortage Spotlights Need for Retention Programs 2Health News:Nationwide Nursing Shortage Spotlights Need for Retention Programs 3
The Arrow 2 Fr. QuadPolar electrode catheter and triple lumen guide system is designed for faster and easier electrophysiology studies. The 2 Fr. QuadPolar catheter is highly torqueable, radiopaque, ...
... of the most simple to perform and useful vascular tests for assessing peripheral vascular disease. With the ... ... ... The ...
... Auto Refractor/Keratometer. Advanced engineering, rapid ... illumination mode make it the most ... 5.5 inch High Quality Monitor ... Rapid, instantaneous readings are taken as ...
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
Medicine Products: